WO2004016737A3 - Nouveaux variants proteiques de htnfsf13b - Google Patents

Nouveaux variants proteiques de htnfsf13b Download PDF

Info

Publication number
WO2004016737A3
WO2004016737A3 PCT/US2003/022505 US0322505W WO2004016737A3 WO 2004016737 A3 WO2004016737 A3 WO 2004016737A3 US 0322505 W US0322505 W US 0322505W WO 2004016737 A3 WO2004016737 A3 WO 2004016737A3
Authority
WO
WIPO (PCT)
Prior art keywords
htnfsf13b
novel
protein variants
tnfsf13b
novel proteins
Prior art date
Application number
PCT/US2003/022505
Other languages
English (en)
Other versions
WO2004016737A2 (fr
Inventor
Kristine Kay Kikly
Radhakrishnan Rathnachalam
Derrick Ryan Witcher
Original Assignee
Lilly Co Eli
Kristine Kay Kikly
Radhakrishnan Rathnachalam
Derrick Ryan Witcher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Kristine Kay Kikly, Radhakrishnan Rathnachalam, Derrick Ryan Witcher filed Critical Lilly Co Eli
Priority to AU2003254001A priority Critical patent/AU2003254001A1/en
Publication of WO2004016737A2 publication Critical patent/WO2004016737A2/fr
Publication of WO2004016737A3 publication Critical patent/WO2004016737A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention présente de nouvelles protéines qui sont des variants dérivés de TNFSF13b humain. Les nouvelles protéines de l'invention sont utiles dans un mode de réalisation permettant d'obtenir une activité TNFSF13b chez un sujet humain souffrant d'un trouble associé à une activité TNFSF13b insuffisante ou absente.
PCT/US2003/022505 2002-08-14 2003-08-11 Nouveaux variants proteiques de htnfsf13b WO2004016737A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003254001A AU2003254001A1 (en) 2002-08-14 2003-08-11 Novel htnfsf13b protein variants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40321402P 2002-08-14 2002-08-14
US60/403,214 2002-08-14

Publications (2)

Publication Number Publication Date
WO2004016737A2 WO2004016737A2 (fr) 2004-02-26
WO2004016737A3 true WO2004016737A3 (fr) 2006-01-05

Family

ID=31888217

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/022505 WO2004016737A2 (fr) 2002-08-14 2003-08-11 Nouveaux variants proteiques de htnfsf13b

Country Status (2)

Country Link
AU (1) AU2003254001A1 (fr)
WO (1) WO2004016737A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030095967A1 (en) 1999-01-25 2003-05-22 Mackay Fabienne BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
CA2554526A1 (fr) 2004-01-29 2005-08-18 Genentech, Inc. Variants du domaine extracellulaire de bcma et utilisations de ceux-ci
AU2005295713B2 (en) 2004-10-13 2011-06-16 The Washington University Use of BAFF to treat sepsis
KR102173260B1 (ko) * 2013-11-19 2020-11-03 리제너론 파마슈티칼스 인코포레이티드 인간화된 b-세포 활성화 인자 유전자를 가지고 있는 비-인간 동물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297367B1 (en) * 1997-12-30 2001-10-02 Chiron Corporation Polynucleotide encoding TNFL1
US6403770B1 (en) * 1996-10-25 2002-06-11 Human Genome Sciences, Inc. Antibodies to neutrokine-alpha

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403770B1 (en) * 1996-10-25 2002-06-11 Human Genome Sciences, Inc. Antibodies to neutrokine-alpha
US6297367B1 (en) * 1997-12-30 2001-10-02 Chiron Corporation Polynucleotide encoding TNFL1

Also Published As

Publication number Publication date
WO2004016737A2 (fr) 2004-02-26
AU2003254001A8 (en) 2004-03-03
AU2003254001A1 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
AU2003242713A1 (en) Complex coacervates containing whey proteins
HK1185894A1 (zh) 衍生自人 蛋白的肽、編碼所述肽的多核苷酸和針對所述肽的抗體
PL375218A1 (en) Recombinant protein variants
WO2004016737A3 (fr) Nouveaux variants proteiques de htnfsf13b
GB0314856D0 (en) Protein expression system
AU2003282338A8 (en) Determination of protein function
AU2003252075A8 (en) Human immunosuppressive protein
AU2003304409A8 (en) Evaluating protein signatures
AU2003295435A1 (en) Biological carriers for the delivery of proteins or peptides
GB0201808D0 (en) Protein
AU2003232513A1 (en) Pain receptor gene and protein
EP1589101A4 (fr) Nouvelle proteine et son gene
AU2002317763A1 (en) Human protein phosphatase 2c-like enzyme
WO2003060148A3 (fr) Molecules d'acide nucleique regulees par l'androgene et proteines codees
WO2005010205A3 (fr) Biomarqueurs nouveaux de l'activite de l'agrecanase
AU2003229752A1 (en) Human rhomboid-related protein
AU2003280316A1 (en) Zymogen-like protein c polypeptides
GB0224307D0 (en) Protein sequence determination
GB0209013D0 (en) Recombinant protein expression
GB0225568D0 (en) Recombinant protein expression
AU2002243563A1 (en) Methods of assessing wolframin protein activity
GB0216601D0 (en) Modified protein
WO2006003427A8 (fr) Proteine impliquee dans le carcinome
GB0209024D0 (en) Gene and protein
AU2002222742A1 (en) Novel stress protein with chaperone activity

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP